跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
F-7H
首页
药物
F-7H
F-7H
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN 103224495 B
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
CRYSTALLINE FORM OF NITROGEN-CONTAINING TETRACYCLIC COMPOUND AND PREPARATION METHOD THEREFOR
EP 4700027 A4
申请人: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Preparation of levofloxacin and forms thereof
EP 1992629 A1
申请人: TEVA PHARMA
优先权: 2002
EP
US
3 件公开
Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
US 7279496 B2
申请人: MERCK PATENT GMBH
优先权: 2001
US
2 件公开
USE OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PROCESSES
US 2009306072 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2002
US
2 件公开
Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives
US 2006094736 A1
申请人: LIN AI J
优先权: 2004
US
2 件公开
Molecules with potent DHFR binding affinity and antibacterial activity
US 9920058 B2
申请人: GEORGIA TECH RES INST
优先权: 2014
US
2 件公开
Pyrroloquinazoline compounds
US 9133203 B2
申请人: XIAO XIANGSHU
优先权: 2014
US
2 件公开
Use of chemotherapeutic agents
CN 101513405 B
申请人: GUENTHER SCHLIMBACH
优先权: 1999
CN
Monomers or symmetric dimers of azo-cations, their preparation, compositions containing them and processes for the dyeing of keratin fibers
EP 1647550 A1
申请人: OREAL
优先权: 2004
EP
第 1 / 3 页
上一页
下一页
药物
反馈